Randomised Trial: One Cycle of Anthracycline-Containing Adjuvant Chemotherapy Compared with Six Cycles of CMF Treatment in Node-Positive, Hormone Receptor-Negative Breast Cancer Patients

Publisher： Karger

E-ISSN： 2296-5262|26|2|115-119

ISSN： 2296-5270

Source： Oncology Research and Treatment, Vol.26, Iss.2, 2003-05, pp. : 115-119

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CT‐Guided Wire Localization for Involved Axillary Lymph Nodes After Neo‐adjuvant Chemotherapy in Patients With Initially Node‐Positive Breast Cancer

By  

THE BREAST JOURNAL, Vol. 22, Iss. 4, 2016-07 ,pp. : 390-396

John Wiley & Sons Inc

Access to resources Recommend Favorite

Combining and sequencing adjuvant chemotherapy and tamoxifen in postmenopausal women with node-positive breast cancer

By Leeper Alexander   Dixon J Michael  

Women's Health, Vol. 6, Iss. 3, 2010-05 ,pp. : 357-360

Future Medicine

Access to resources Recommend Favorite

Which Patients with Estrogen Receptor-Positive Early Breast Cancer Should Be Treated with Adjuvant Chemotherapy?

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 18-22

Karger

Access to resources Recommend Favorite

Adjuvant Chemotherapy for the Treatment of HER2-Positive Early Breast Cancer

By  

Oncology, Vol. 77, Iss. 1, 2010-02 ,pp. : 14-17

Karger

Access to resources Recommend Favorite

Physical activity and survival of postmenopausal, hormone receptor–positive breast cancer patients: Results of the Tamoxifen Exemestane Adjuvant Multicenter Lifestyle study

By  

CANCER, Vol. 120, Iss. 18, 2014-09 ,pp. : 2847-2854

John Wiley & Sons Inc

Access to resources Recommend Favorite